← Back to Analyst Consensus 
CNTX Buy
Context Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 16, 2026 | Maxim Group | maintain | Buy → Buy | — | 42% |
| Mar 24, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Mar 24, 2026 | Guggenheim | reiterate | Buy → Buy | — | 52% |
| Mar 24, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Dec 22, 2025 | Jones Trading | initiate | — → Buy | $7 | 50% |
| Nov 6, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Nov 6, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Oct 16, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Oct 2, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $0 | 50% |
| Sep 18, 2025 | Guggenheim | initiate | — → Buy | $5 | 52% |
| Aug 7, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Aug 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Jun 26, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $4 | 54% |
| May 8, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Apr 29, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Apr 21, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Apr 9, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Mar 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 21, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Jan 15, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Jan 8, 2025 | JMP Securities | initiate | — → Market Outperform | $4 | 53% |
| Nov 25, 2024 | D. Boral Capital | initiate | — → Buy | $9 | 34% |
| Sep 23, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Sep 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Jul 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| May 16, 2024 | Piper Sandler | initiate | — → Overweight | $4.5 | 54% |
| May 9, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| May 9, 2024 | Maxim Group | maintain | Buy → Buy | $10 | 42% |
| Mar 21, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Nov 1, 2023 | HC Wainwright & Co. | upgrade | Neutral → Buy | $5 | 44% |
| Sep 11, 2023 | Maxim Group | initiate | — → Buy | $4 | 42% |
| Jun 6, 2023 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Mar 23, 2023 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Feb 7, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $4 | 44% |
| Feb 2, 2022 | HC Wainwright & Co. | initiate | — → Buy | $6 | 44% |
| Jan 24, 2022 | ThinkEquity | initiate | — → Buy | $10 | — |
Price Target Trend
Apr 2, 2026 Latest: $4.14 Oct 25, 2026
EPS Estimates
+1y $-0.44
Lo: $-0.59 Hi: $-0.37
7 analysts 0q $-0.11
Lo: $-0.16 Hi: $-0.07
8 analysts +1q $-0.11
Lo: $-0.17 Hi: $-0.08
8 analysts 0y $-0.46
Lo: $-0.57 Hi: $-0.40
8 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days